NL
CC icon

Navalign LLC’s Chemours CC Stock Holding History

Navalign LLC’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-82
Closed -$967 – 173
2025
Q4 		$967 Buy
+82
New +$1.05K ﹤0.01% 452

Other funds holding CC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
WHCM
Wolf Hill Capital Management Greenwich, Connecticut $1.03B AUM 80.44% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Navalign LLC's CC Position: Q1 2026 in Review

Navalign LLC sold out of Chemours (CC) in Q1 2026, closing a stake of 82 shares — an estimated $967 sold.

Navalign LLC first reported a position in CC in Q4 2025 and held it in 1 quarter. The position peaked at $967 in Q4 2025. 448 funds tracked by Wall St. Rank hold CC as of Q1 2026.

  • Navalign LLC reported no remaining Chemours position as of Q1 2026 after selling out during the quarter.
  • Navalign LLC sold 82 Chemours shares in Q1 2026, an estimated $967.
  • Navalign LLC first reported a position in Chemours in Q4 2025 and held it in 1 quarter.
  • Navalign LLC's Chemours position peaked at $967 in Q4 2025.
  • 448 funds tracked by Wall St. Rank held Chemours as of Q1 2026.

Based on Navalign LLC's 13F filing for Q1 2026, filed 29 Apr 2026.